SCHEMBL23360545

SCHEMBL23360545

O=C(O)N1CC[C@@H](Nc2ccnc3ccc(Cl)cc23)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
KMT5B Q4FZB7 2/20 0.49
KMT5C Q86Y97 2/20 0.49
IDO1 P14902 4/20 0.48
TDO2 P48775 4/20 0.48
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
NSD2 O96028 1/20 0.44
MAPKAPK2 P49137 1/20 0.43
CNR1 P21554 3/20 0.42
PDGFRB P09619 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
IDE P14735 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360548 1.00 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1KMT2AKMT5B
SCHEMBL23360560 0.87 GFER (0.48) IDO1TDO2CCNCCDK8CYP2C8
SCHEMBL23360562 0.87 GFER (0.48) IDO1TDO2CCNCCDK8CYP2C8
SCHEMBL23360245 0.87 KMT2A (0.52) ALDH1A1KDM4EMEN1KMT2AKMT5B
SCHEMBL23360247 0.87 KMT2A (0.52) ALDH1A1KDM4EMEN1KMT2AKMT5B
SCHEMBL28833982 0.85 CNR1 (0.55) ALDH1A1KDM4EMEN1KMT2AIDO1
SCHEMBL29933511 0.85 CNR1 (0.55) ALDH1A1KDM4EMEN1KMT2AIDO1
SCHEMBL23360554 0.84 MCHR1 (0.53) KDM4ECYP2D6NOS1NOS2MAPK1
SCHEMBL23360083 0.84 HDAC8 (0.45) ALDH1A1KDM4EMEN1KMT2AIDO1
SCHEMBL23360081 0.84 HDAC8 (0.45) ALDH1A1KDM4EMEN1KMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL ALDH1A1 439/4885KDM4E 1644/4885MEN1 2004/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL ALDH1A1 439/4885KDM4E 1644/4885MEN1 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.